Age
Item
age 18 years and above
boolean
C0001779 (UMLS CUI [1])
Gender
Item
male or female
boolean
C0079399 (UMLS CUI [1])
Informed Consent
Item
able to provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
willing and able to comply with the protocol for the duration of the study.
boolean
C0525058 (UMLS CUI [1])
Criteria Quantity Fulfill
Item
has one or more of
boolean
C0243161 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Age
Item
age 40 years or above
boolean
C0001779 (UMLS CUI [1])
Renal Insufficiency | Creatinine measurement, serum | Glomerular Filtration Rate Calculated
Item
impaired renal function (creatinine >120 mmol/l or calculated glomerular filtration rate <60mls/min)
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0017654 (UMLS CUI [3,1])
C0444686 (UMLS CUI [3,2])
Diabetes Mellitus Type Any
Item
diagnosis of diabetes mellitus (any type)
boolean
C0011849 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C1552551 (UMLS CUI [1,3])
Hepatitis B vaccination
Item
history of prior hepatitis b vaccination
boolean
C0474232 (UMLS CUI [1])
Vaccines allergy Serious | Medical contraindication Hepatitis B vaccination
Item
history of serious vaccine allergy if in the opinion of the investigator this represents a contraindication to hepatitis b vaccination
boolean
C0571550 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0474232 (UMLS CUI [2,2])
Childbearing Potential | Exception Use of Contraceptive methods | Contraceptives, Oral | Intrauterine Devices | Contraception, Barrier
Item
women of childbearing potential unless using a reliable and appropriate contraceptive method, specifically oral contraceptive pill, intrauterine device or mechanical barrier device.
boolean
C3831118 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,3])
C0009905 (UMLS CUI [3])
C0021900 (UMLS CUI [4])
C0004764 (UMLS CUI [5])
Pregnancy | Breast Feeding
Item
pregnant or lactating women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Systemic autoimmune disease | Wegener's Granulomatosis | Lupus Erythematosus, Systemic | Guillain-Barre Syndrome | Scleroderma | Multiple Sclerosis
Item
history of systemic autoimmune disease including wegener's granulomatosis, systemic lupus erythematosus, guillain-barre, scleroderma or multiple sclerosis.
boolean
C2895206 (UMLS CUI [1])
C3495801 (UMLS CUI [2])
C0024141 (UMLS CUI [3])
C0018378 (UMLS CUI [4])
C0011644 (UMLS CUI [5])
C0026769 (UMLS CUI [6])
Study Subject Participation Status | Investigational New Drugs
Item
participation in another clinical trial with an investigational agent within 28 days of the scheduled date of first immunization.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Medical condition Serious Impairing Study Subject | Medical condition Serious Impairing Clinical Trial | Social Condition Impairing Study Subject | Social Condition Impairing Clinical Trial | Mental condition Impairing Study Subject | Mental condition Impairing Clinical Trial
Item
any other serious medical, social or mental condition that, in the opinion of the investigator, would be detrimental to the subjects or the study.
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0221099 (UMLS CUI [1,3])
C0681850 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0221099 (UMLS CUI [2,3])
C0008976 (UMLS CUI [2,4])
C0037403 (UMLS CUI [3,1])
C0221099 (UMLS CUI [3,2])
C0681850 (UMLS CUI [3,3])
C0037403 (UMLS CUI [4,1])
C0221099 (UMLS CUI [4,2])
C0008976 (UMLS CUI [4,3])
C3840291 (UMLS CUI [5,1])
C0221099 (UMLS CUI [5,2])
C0681850 (UMLS CUI [5,3])
C3840291 (UMLS CUI [6,1])
C0221099 (UMLS CUI [6,2])
C0008976 (UMLS CUI [6,3])